📣 VC round data is live. Check it out!
- Public Comps
- Sopharma
Sopharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sopharma and similar public comparables like BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies and more.
Sopharma Overview
About Sopharma
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
Founded
1933
HQ

Employees
5.6K
Website
Sectors
Financials (FY)
EV
$1B
Valuation Multiples
Start free trialSopharma Financials
Sopharma reported last fiscal year revenue of $2B and EBITDA of $156M.
In the same fiscal year, Sopharma generated $368M in gross profit, $156M in EBITDA, and $78M in net income.
Revenue (LTM)
Sopharma P&L
In the most recent fiscal year, Sopharma reported revenue of $2B and EBITDA of $156M.
Sopharma is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 10%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Sopharma Stock Performance
Sopharma has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Sopharma's stock price is $2.16.
Sopharma share price increased by 6.9% in the last 30 days, and decreased by 72.2% in the last year.
Sopharma has an EPS (earnings per share) of $0.15.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.0% | 6.9% | -1.1% | -72.2% | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSopharma Valuation Multiples
Sopharma trades at 0.7x EV/Revenue multiple, and 7.3x EV/EBITDA.
EV / Revenue (LTM)
Sopharma Financial Valuation Multiples
As of May 23, 2026, Sopharma has market cap of $1B and EV of $1B.
Sopharma has a P/E ratio of 14.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sopharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sopharma Margins & Growth Rates
In the most recent fiscal year, Sopharma reported gross margin of 23%, EBITDA margin of 10%, and net margin of 5%.
Sopharma Margins
Sopharma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Operational KPIs
Sopharma's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Competitors
Sopharma competitors include BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies, Paul Hartmann, Menicon, Arjo, Salus, Cerus and Chengzhi.
Most Sopharma public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 11.5x | 10.7x | 44.5x | 41.2x | |||
| 0.6x | 0.6x | 7.0x | 6.9x | |||
| 1.4x | 1.2x | 7.2x | 7.2x | |||
| 17.0x | 10.7x | (12.8x) | (12.2x) | |||
| 0.4x | — | 3.9x | — | |||
| 1.3x | 1.3x | 8.7x | 7.5x | |||
| 0.6x | 0.6x | 3.7x | 3.7x | |||
| 0.7x | — | 17.1x | — | |||
This data is available for Pro users. Sign up to see all Sopharma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sopharma
| When was Sopharma founded? | Sopharma was founded in 1933. |
| Where is Sopharma headquartered? | Sopharma is headquartered in Bulgaria. |
| How many employees does Sopharma have? | As of today, Sopharma has over 5K employees. |
| Is Sopharma publicly listed? | Yes, Sopharma is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Sopharma? | Sopharma trades under SFA ticker. |
| When did Sopharma go public? | Sopharma went public in 2000. |
| Who are competitors of Sopharma? | Sopharma main competitors include BioLife Solutions, Shinva, Gerresheimer, Kestra Medical Technologies, Paul Hartmann, Menicon, Arjo, Salus, Cerus, Chengzhi. |
| What is the current market cap of Sopharma? | Sopharma's current market cap is $1B. |
| What is the current revenue of Sopharma? | Sopharma's last fiscal year revenue is $2B. |
| What is the current EV/Revenue multiple of Sopharma? | Current revenue multiple of Sopharma is 0.7x. |
| Is Sopharma profitable? | No, Sopharma is not profitable. |
| How many companies Sopharma has acquired to date? | Sopharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Sopharma has invested to date? | Sopharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Sopharma
Lists including Sopharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.